William A. Haseltine, Contributor

Author's posts

Symptomatic Covid-19 Infection Is Associated With An Increased Risk Of Overactive Bladder Symptoms

Symptomatic Covid-19 infection is associated with the risk of developing or worsening overactive bladder.

Reimagining Alzheimer’s (Part 6): The Many Effects Of The APOE4 Variant

A novel aspect of the APOE4 genetic predisposition to Alzheimer’s is uncovered and leads to the potential for new diagnostic methods and treatment

Crimean-Congo Hemorrhagic Fever Virus Monoclonal Antibodies: A Work In Progress

A recent study on Crimean-Congo Hemorrhagic Fever Virus may pave the way for a new monoclonal antibody treatment in the near future.

Covid-19 And Children: What We Know

Why do children experience milder symptoms on average compared to adults? Do children experience Long Covid, and what makes them different? What is MIS-C and what is its prevalence? I explore recent research to answer these questions.

The N Protein, A New Target For Anti-Covid Drugs

FDA-approved drug inhibits SARS-CoV-2 nucleocapsid phosphorylation and viral replication.

Do You Have The “Thin” Gene?

Happy Thanksgiving! As you dig into your Thanksgiving dinner, a time when many of us overeat, you may well ask: Will I regret it tomorrow when I check my weight? Will it be ok?

CRISPR Technology To Simplify And Enhance CAR T Cancer Treatment

Researchers find that combining novel gene-editing CRISPR technology with CAR T therapy could simplify and improve CAR T therapy in one fell swoop.

Hope For A New Treatment On The Horizon For Zika Virus

An uncommon monoclonal antibody treatment for Zika Virus may be on the horizon in the wake of new research on the pathogen.

Researchers Control Cancer Treatment With New Innovation: CAR T Switch(blade)

The early study result from Scripps Research suggests that switchable CAR T cells are not only safe to use for patients with B cell cancers, but comparatively safer and more effective than some CAR T therapies currently on the market.

New Monoclonal Antibody For Treatment Of Malaria

A new monoclonal antibody treatment for malaria may soon aid the millions impacted by the disease annually.